Evonik Industries Reports 13% Increase in Q3 Sales
Evonik Industries reported a significant increase in third-quarter sales, rising 13% compared to the same period last year. This represents the company's strongest quarterly growth since the third quarter of 2022. Looking ahead, the company has provided an updated outlook for 2026, targeting adjusted EBITDA in the upper half of its projected range between €2.0 billion and €2.2 billion. These results come amid ongoing market speculation regarding potential takeover interest from BASF.
Tickers: $BASFY
Topics: EBITDA outlook M&A sales growth takeover bid
Read the full article at Seeking Alpha
Part of the story JAKKS Pacific Reports 20% Increase in Q3 Net Sales and Declares Quarterly Dividend (4 articles)